# SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

> **NCT07342621** · — · RECRUITING · sponsor: **Outcomes'10** · enrollment: 41 (estimated)

## Conditions studied

- Cow's Milk Protein Allergy (CMPA)
- Food Hypersensitivity
- Infant Nutrition Disorders
- Gut Microbiota

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07342621
- **Lead sponsor:** Outcomes'10
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-07
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-04
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342621, "SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07342621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*